Consensus-based recommendation for surveillance of alopecia

This page is part of the PanCare follow-up recommendations for surveillance of late effects. Click here, for more information on these recommendations.

Click here, to read this recommendation in PLAIN language.

Who is at risk for alopecia?

  • Some CAYA cancer survivors treated with chemotherapy, radiotherapy and/or HSCT may experience poor hair re-growth or alopecia

What should be done if the survivor experiences any distress?

  • Discuss the availability of cosmetic solutions and/or psychological support